NCT04954027

Brief Summary

This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence. 5 visits are planned during the study :

  • the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online
  • 4 telephone interviews for follow-up by investigator.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
24mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
5.2 years until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

June 29, 2021

Last Update Submit

June 3, 2025

Conditions

Keywords

implicit approachpost-weaning prognostic factor

Outcome Measures

Primary Outcomes (1)

  • Implicit attachment and onsumption

    Assessment of the link between implicit attachment and changes in consumption after a 12-month follow-up

    12 months

Study Arms (1)

Patients with a use-related disorder weaning for a substance

Behavioral: Questionnaires

Interventions

QuestionnairesBEHAVIORAL

5 visits are planned during the study : * the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator

Patients with a use-related disorder weaning for a substance

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a use-related disorder weaning for a substance, supported within the addictology sector of Henri Laborit Hospital

You may qualify if:

  • Patients between 18 and 65 years old
  • Patients with a use-related disorder as defined by DSM5
  • Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
  • Having expressed non-opposition to participating in the study after receiving written information.

You may not qualify if:

  • Person who cannot read or write
  • Simultaneous participation in a therapeutic trial involving oxytocin
  • Patients protected by law
  • Patients who do not have French as their native language
  • Patients who, in the opinion of the investigator, are unable to complete the questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Behavior, Addictive

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Compulsive BehaviorImpulsive BehaviorBehavior

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Wilfried SERRA, Dr

    Centre Hospitalier Henri Laborit

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 8, 2021

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share